Financial Performance - The company's operating revenue for Q1 2025 was CNY 134,286,929.36, representing a 16.87% increase compared to CNY 114,906,354.26 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 5,450,922.09, an improvement from a loss of CNY 33,616,386.19 in the previous year[4] - The basic and diluted earnings per share were both negative CNY 0.04, an improvement from negative CNY 0.25 in the same period last year[4] - Net profit for Q1 2025 was -¥5.45 million, an improvement from -¥33.62 million in Q1 2024, indicating a significant reduction in losses[20] Cash Flow - The net cash flow from operating activities was a negative CNY 24,458,924.76, worsening from a negative CNY 14,945,672.69 year-on-year[4] - Cash flow from operating activities showed a net outflow of -¥24.46 million in Q1 2025, compared to -¥14.95 million in Q1 2024[24] - Cash inflow from investment activities was ¥115.89 million in Q1 2025, a decrease from ¥206.91 million in Q1 2024[24] - Cash outflow from investment activities totaled ¥133.05 million in Q1 2025, down from ¥149.18 million in Q1 2024[24] - The net increase in cash and cash equivalents was -$28,976,358.19, a significant decline from an increase of $54,317,165.21 in the prior period[25] - The ending balance of cash and cash equivalents was $56,241,866.39, down from $104,036,896.49, representing a decrease of approximately 46.0%[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,179,462,076.18, a decrease of 1.86% from CNY 1,201,819,195.09 at the end of the previous year[5] - The equity attributable to shareholders decreased by 6.68% to CNY 739,360,356.23 from CNY 792,297,427.81[5] - Total liabilities increased to ¥440.10 million in the latest reporting period from ¥409.52 million previously, indicating a rise in financial obligations[17] - Current liabilities decreased to RMB 353,429,580.57 from RMB 376,336,646.15, showing a reduction of approximately 6.06%[16] Research and Development - Research and development expenses totaled CNY 35,440,733.04, down 19.06% from CNY 43,785,860.20, with R&D expenses accounting for 26.39% of operating revenue, a decrease of 11.72 percentage points[5] - Research and development expenses for Q1 2025 were ¥35.44 million, down 19% from ¥43.79 million in Q1 2024[20] Operational Strategy - The company plans to continue focusing on improving operational efficiency and reducing costs to enhance profitability in future quarters[7] Shareholder and Financing Activities - The company has no significant changes in the shareholder structure or related party transactions during the reporting period[12] - The company raised ¥60 million through borrowings in Q1 2025, compared to ¥40 million in Q1 2024, reflecting increased financing activities[24] - Cash flow from financing activities totaled $48,362,784.97, an increase from $28,466,172.98 in the previous period, reflecting a growth of approximately 70.0%[25]
皖仪科技(688600) - 2025 Q1 - 季度财报